TORONTO, CHICAGO and MONTREAL, May 07, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”...
MONTREAL, April 08, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”...
TORONTO, CHICAGO and MONTREAL, March 23, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the...
Acquisition Expected to be Immediately Accretive to Adjusted EBITDA1 Announces US$20 Million Credit Facility...
Q3 2020 Metoject® unit market demand increased 88%1; Rupall™ unit market demand increased 62%2; and...
MONTREAL, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV:...
Q2 2019 Metoject™ unit market demand increased 115%1;Rasuvo™ unit market demand increased 15%2; andRupall™ unit...
MONTREAL, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV:...
MONTREAL, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV:...
MONTREAL, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV:...
MONTREAL, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”) (TSXV: MDP, OTCQB:...
TORONTO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV:...
MONTREAL, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”...
Record Revenue of $16.1 Million $0.5 million of Adjusted EBITDA Medexus management to host conference call at...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.